Telix Pharmaceuticals | TLX - EPS Earnings Per Share

Stock Price
13.95
Daily Change
0.37 2.72%
Monthly
36.76%
Yearly
-42.87%
Q2 Forecast
12.67

Telix Pharmaceuticals reported AUD-0.05 in EPS Earnings Per Share for its fiscal semester ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025H2 Dec/2025 0.36 0.14 Feb/19
FY2025H1 Jun/2025 0.02 0.27 0.09 Aug/20
FY2024H2 Dec/2024 0.14 0.10 0.05 Feb/20
FY2024H1 Jun/2024 0.09 0.15 -1874000.0000 Aug/21
FY2023H2 Dec/2023 0.05 0.05 -0.10 Feb/22




Eps Change Date
Cochlear AUD 3.13 0.25 Dec/2025
CSL USD 5.07 3 Dec/2025
Integral Diagnostics AUD 0.04 0.01 Dec/2024
Mayne Pharma AUD -0.15 0.74 Dec/2025
Medical Developments International AUD 0 0 Dec/2025
Mesoblast USD -0.03 0.01 Dec/2025
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Pacific Edge NZD -0.02 0 Dec/2025
Paradigm Biopharmaceuticals AUD -0.06 0.03 Dec/2025
Polynovo AUD 0.01 0 Dec/2025
PYC Therapeutics AUD -0.04 0.01 Dec/2025
Ramsay Health Care AUD 0.66 0.01 Dec/2025
ResMed USD 2.68 0.19 Dec/2025
Sonic Healthcare AUD 0.53 0.04 Dec/2025